[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100593511":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":15,"locations":10,"responsibleParty":23,"collaborators":25,"id":29,"slug":30,"hasResults":31,"nctId":32,"briefTitle":33,"officialTitle":33,"acronym":10,"eligibilityCriteria":34,"healthyVolunteers":35,"sex":36,"minAge":37,"maxAge":10,"enrollmentInfo":38,"targetDuration":10,"studyType":41,"phases":10,"briefSummary":42,"conditions":43,"keywords":10,"overallStatus":46,"whyStopped":10,"lastUpdateSubmitDate":47,"lastUpdatePostDateStruct":48,"startDateStruct":51,"completionDateStruct":53,"leadSponsor":55,"locationsCount":10},{"fullName":5,"class":6},"Viome","INDUSTRY",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"ALS Cohort",null,"Patients of Dr. Espíndola at UFSC that are diagnosed with ALS and meet the inclusion\u002Fexclusion criteria.",{"label":13,"type":10,"description":14,"interventionNames":10},"Control Cohort","Those that meet the inclusion\u002Fexclusion criteria, do not have ALS, and generally are healthy.",[16,21],{"name":17,"role":18,"phone":19,"phoneExt":10,"email":20},"Raquel Clinical Research Coordinator, BS","CONTACT","425-368-5248","studies@viome.com",{"name":22,"role":18,"phone":10,"phoneExt":10,"email":20},"Momo Chief Science Officer, Head of Clinical Research, PhD",{"type":24,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[26],{"name":27,"class":28},"Universidade Federal de Santa Catarina","OTHER","100593511","systems-biology-of-amyotrophic-lateral-sclerosis-als-100593511",false,"NCT07007390","Systems Biology of Amyotrophic Lateral Sclerosis (ALS)","Inclusion Criteria:\n\n* Patient of Dr. Espíndola at UFSC\n\nExclusion Criteria:\n\n\\-",true,"ALL","18 Years",{"count":39,"type":40},20,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to identify molecular features in multiple clinical samples and\u002For the patient environment that are associated with ALS. Participants will collect biological samples and answer questionnaires regarding their health at each appointment with their ALS practitioner.",[44,45],"ALS","ALS (Amyotrophic Lateral Sclerosis)","NOT_YET_RECRUITING","2025-06-02",{"date":49,"type":50},"2025-06-05","ACTUAL",{"date":52,"type":40},"2025-06-01",{"date":54,"type":40},"2030-05-01",{"name":5,"class":6}]